SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000863894-22-000009
Filing Date
2022-05-12
Accepted
2022-05-12 12:15:20
Documents
80
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q veru-20220331x10q.htm   iXBRL 10-Q 3104295
2 EX-31.1 veru-20220331xex31_1.htm EX-31.1 15764
3 EX-31.2 veru-20220331xex31_2.htm EX-31.2 15989
4 EX-32.1 veru-20220331xex32_1.htm EX-32.1 12213
  Complete submission text file 0000863894-22-000009.txt   12290734

Data Files

Seq Description Document Type Size
5 EX-101.SCH veru-20220331.xsd EX-101.SCH 58713
6 EX-101.CAL veru-20220331_cal.xml EX-101.CAL 78914
7 EX-101.DEF veru-20220331_def.xml EX-101.DEF 195061
8 EX-101.LAB veru-20220331_lab.xml EX-101.LAB 472594
9 EX-101.PRE veru-20220331_pre.xml EX-101.PRE 392472
74 EXTRACTED XBRL INSTANCE DOCUMENT veru-20220331x10q_htm.xml XML 2973344
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 22916710
SIC: 2834 Pharmaceutical Preparations